STAT+: Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple cinnamon French toast, a yummy concoction that has quickly become one of our favorites. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. We are always happy to make new pen pals. …
A new generation of Covid-19 vaccines that can be inhaled or sprayed up the nose — instead of taken by injection — will begin rolling out in Asia, though just how effective they are remains to be seen, The Wall Street Journal explains. Regulators in China and India have green-lighted distribution of vaccines delivered through the mouth or nose, a delivery that scientists say holds the promise of more potent protection against Covid-19 by better reducing infections and preventing the disease’s spread among vaccinated people because they work in the nose and lungs where transmission first happens.
Continue to STAT+ to read the full story…
